Aminoglycosides: an update on indications, dosing and monitoring

Australian Prescriber · Published 2025-08-11 · DOI 10.18773/austprescr.2025.038

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.18773/austprescr.2025.038

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The Safety of Single Aminoglycoside Dose in Emergency Departments ( SAD ‐ ED ) Among Patients With and Without Chronic Kidney Disease: A Retrospective Cohort Study · EMA - Emergency Medicine Australasia · 2026 · Cites or is cited by this article
• New Drug: Spesolimab for generalised pustular psoriasis · Australian Prescriber · 2025 · Same journal
• Cardio-kidney-metabolic (CKM) syndrome · Australian Prescriber · 2026 · Same journal
• Using pharmacogenomics to personalise drug therapy: which drugs, when and how · Australian Prescriber · 2025 · Same journal
• Top 10 drugs 2024–25 · Australian Prescriber · 2025 · Same journal
• Preventing infections in immunosuppressed patients · Australian Prescriber · 2026 · Same journal
• New Drug: Edaravone for amyotrophic lateral sclerosis · Australian Prescriber · 2025 · Same journal
• New Drug: Fenfluramine for seizures associated with Dravet syndrome and Lennox–Gastaut syndrome · Australian Prescriber · 2025 · Same journal
• Acne vulgaris: a clinical update · Australian Prescriber · 2026 · Same journal
• Medicinal Mishap: Near-fatal reaction associated with cotrimoxazole, metformin and kidney impairment · Australian Prescriber · 2025 · Same journal